Advances in Glycobiology (Technical Insights)

Frost & Sullivan
June 30, 2010
SKU: MC2827052
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update
7/7/2014 | published by: GlobalData
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky mucus which clogs the lungs and leads to  |  read more...
USD 5,995
Proteins in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Proteins in Oncology Drug Pipeline Update 2014 This drug pipeline update covers proteins, excluding antibodies, as drugs for the treatment of cancer. There are today 326 companies plus partners developing 359 protein drugs in 667 developmental projects  |  read more...
USD 6,746
Conference Documentation: Immunogenicity
7/14/2014 | published by: SMI Publishing, Ltd
Conference Documentation: Immunogenicity SMi are launching an Immunogenicity Conference, a two day event designed to become the leaders’ favourite with an ever growing demand for biologic therapeutics in the Pharmaceutical Industry.  |  read more...
USD 788
IL-7 Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
IL-7 Signaling Pathway in Oncology Drug Pipeline Update 2014 IL-7 signaling pathway mainly activates the JAK/STAT signaling module. There are today 66 companies plus partners developing 72 IL-7 pathway targeting drugs in 299 developmental projects in cancer.  |  read more...
USD 2,246
IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2014 The IL-9 signaling pathway activates Jak/STAT and MAPK signaling modules. There are today 63 companies plus partners developing 67 IL-9 pathway targeting drugs in 275 developmental projects in  |  read more...
USD 4,496
Immunotherapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Immunotherapy in Oncology Drug Pipeline Update 2014 Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the fields of antibodies,  |  read more...
USD 11,025
Leukemia Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Leukemia Drug Pipeline Update 2014 Leukemia includes a broad variety of histological separate disorders which make the leukemia market segmented. There are today 292 companies plus partners developing 417 leukemia drugs in 632 developmental projects in cancer.  |  read more...
USD 6,746
IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2014 The IL-4 signaling pathway stimulates the JAK/STAT and MAPK signaling modules. There are today 149 companies plus partners developing 217 IL-4 pathway targeting drugs in 724 developmental projects  |  read more...
USD 6,746
IL-5 Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
IL-5 Signaling Pathway in Oncology Drug Pipeline Update 2014 The IL-5 singaling pathway activates the JAK/STAT and Raf/MAPK signaling modules. There are today 124 companies plus partners developing 167 IL-5 pathway targeting drugs in 667 developmental projects  |  read more...
USD 6,746
Oncology Drug Pathway Analyzer (Premium Version)
7/15/2014 | published by: BioSeeker Group AB
Oncology Drug Pathway Analyzer (Premium Version) EXTRA: Free online updates for a year Get instant, interactive pathway modeling on more than 3,500 cancer drugs across more than 100 different cancer types. Drug targets and their pathways are the  |  read more...
USD 44,550
 

SELECT A LICENSE

    Electronic Access
Single User Fulfilled By Publisher
  USD 6,500  
    Electronic Access
Global Site License Fulfilled By Publisher
  USD 8,000  
    Hard Copy Mail Delivery  USD 7,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!